Aug 2026· Frontiers in Immunology· Vol 17· 0 citations· 31 references
Medicine
TL;DR
These gain-of-function data support a profibrotic effect of increased NUFIP1 in experimental models and support the clinical relevance of NUFIP1 expression in human IPF.
Abstract
Background Fibroblast activation and extracellular matrix deposition are central features of IPF, but the molecular programs that sustain pathogenic fibroblast states remain incompletely defined. NUFIP1 has been implicated in ribonucleoprotein biology and cellular stress responses, yet its role in pulmonary fibrosis is unknown. Methods NUFIP1 expression was examined in lung tissues from patients with IPF, bleomycin-induced pulmonary fibrosis in mice, and TGF-β1-stimulated human lung fibroblasts. Gain-of-function studies were performed in MRC-5 fibroblasts and in mice using AAV-mediated NUFIP1 overexpression. The association between NUFIP1 and ZNHIT3 was assessed by co-immunoprecipitation and surface plasmon resonance. The effect of CB-839 on NUFIP1-ZNHIT3 interaction, fibroblast activation, and pulmonary fibrosis was evaluated in vitro and in vivo. Public bulk and single-cell RNA-seq datasets were analyzed to assess the clinical relevance of NUFIP1 expression in human IPF. Results NUFIP1 expression was increased in IPF lung tissue and showed spatial overlap with Vimentin-positive fibrotic regions. AAV-mediated NUFIP1 gain of function was sufficient to induce fibrotic remodeling relative to vector controls, with a magnitude comparable to a separate bleomycin reference group. NUFIP1 associated with ZNHIT3, and CB-839 altered the apparent association under the tested conditions while reducing NUFIP1-associated fibrotic readouts. Public transcriptomic analyses supported a modest donor-level increase in whole-lung NUFIP1 expression and detected NUFIP1 across multiple lineages, including IPF-associated fibroblast states. Conclusions These gain-of-function data support a profibrotic effect of increased NUFIP1 in experimental models. ZNHIT3 is a candidate binding partner, and CB-839 reduced NUFIP1-associated fibrotic readouts at the tested dose. Pathway specificity, endogenous necessity, and clinical relevance remain to be established.
WISP1 links WNT signaling, cytoskeletal remodeling, and metabolism to drive fibroblast-mediated fibrosis in CD, positioning WISP1 as a promising antifibrotic target.
A. Buck, Chiara Writz, Max Umbach et al.· Gastroenterology· 0 citations
A critical role for the lysine methyltransferase Suv39h1 in regulating fibroblast-myofibroblast transition (FMyT) and renal fibrosis is identified and Suv39h1-mediated regulation as a previously unrecognized facet of renal fibrogenesis is identified.
Xiao-Yan Wu, Ya-Jun Luo, Caiyi Wu et al.· Journal of Advanced Research· 0 citations
Idiopathic pulmonary fibrosis (IPF) is driven by persistent fibroblast activation, excessive extracellular matrix (ECM) deposition, and progressive tissue stiffening, yet the mechanosensitive signaling programs that sustain fibrotic fibroblast states remain incompletely defined. Here, we investigated the association be...
Xiao-Hua Wang, Jin-Ping Liu, A. Sang· Biochemical and Biophysical...· 0 citations
BACKGROUND
Liver fibrosis is driven by excessive extracellular matrix (ECM) deposition following chronic injury. Mutations in the human zinc finger protein 469 (ZNF469) cause Brittle Cornea Syndrome, a systemic connective tissue disorder, yet its functional role in hepatic fibrogenesis remains unexplored in vivo. This...
PKN2 loss drives fibroblast reprogramming and aberrant ECM remodelling, establishing PKN2 as an important regulator of pulmonary fibroblast homeostasis and tissue repair.
Catherine E. McMullan, Oscar A. Peña, P. Rajasekar et al.· bioRxiv· 0 citations
ABSTRACT Idiopathic pulmonary fibrosis (IPF) is a lethal lung disorder that is associated with aberrant lipid metabolism. N6‐methyladenosine (m6A) methylation is involved in IPF progression. However, whether METTL3, a m6A methyltransferase, modulates lipid metabolism in IPF remains unknown. In this study, we aimed to i...
Qi-Ping Liu, Rui Xu, Xian-Zhi Du· Journal of Cellular and Mole...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.